← Leaderboards
Anju Bansal
University Of Alabama At Birmingham
$2,136,871
Attributed
$4,730,430
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,730,430 · 3
By mechanism
R01$4,322,055 · 2
R21$408,375 · 1
Top collaborators
- Paul A. Goepfert6 shared
- Nilam Sanjib Banerjee2 shared
- William M Geisler2 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Waldemar A. Carlo$27,528,882
- Anupam Agarwal$17,840,868
- William M Geisler$14,663,241
- Alan Thevenet N. Tita$31,628,801
- Edward E Partridge$43,798,134
Research focus
Cd8-Positive T-LymphocytesInfectionInsightCellsAntigensImmunePreventionT-LymphocyteMediatingPeptidesModalityFutureGene ExpressionPathogenMolecularPhenotypeInterferon Type IiChronic InfectionImmunologic SurveillanceHla-A GeneAllelesChronicBiologicalHiv Infections
Grant awards (8)
Onco-immunologic factors contributing to OPSCC among people living with HIV$697,916
R01 · FY2025 · DE · contact PI
Onco-immunologic factors contributing to OPSCC among people living with HIV$672,147
R01 · FY2024 · DE · contact PI
Defining the biological relevance of HIV specific HLA-E restricted CD8 T cell responses$614,212
R01 · FY2024 · AI
The role of Chlamydia trachomatis specific HLA-E restricted CD8 T cell responses in clearance of infection$185,625
R21 · FY2024 · AI · contact PI
Defining the biological relevance of HIV specific HLA-E restricted CD8 T cell responses$630,755
R01 · FY2023 · AI
The role of Chlamydia trachomatis specific HLA-E restricted CD8 T cell responses in clearance of infection$222,750
R21 · FY2023 · AI · contact PI
Defining the biological relevance of HIV specific HLA-E restricted CD8 T cell responses$1,050,409
R01 · FY2022 · AI
Defining the biological relevance of HIV specific HLA-E restricted CD8 T cell responses$656,616
R01 · FY2021 · AI